Clinical trial
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing…
NCT00459407 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00459407 |
|---|---|
| Title | Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate |
| Official title | Phase Ib Study of Polyphenon E in a Pre-prostatectomy Prostate Cancer Cohort |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer |
| Intervention type | Dietary Supplement, Drug, Other, Procedure |
| Interventions | defined green tea catechin extract, placebo, immunohistochemistry staining method, immunoenzyme technique, laboratory biomarker analysis, biopsy, mass spectrometry, high performance liquid chromatography |
| Enrollment | 50 |
| Start date | Mar 1, 2007 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Apr 11, 2007 |
| Last update posted | Oct 8, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: